Description of Pantera Lux paclitaxel-releasing balloons and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis

EuroIntervention

Volumn 7, Issue SUPPL. K, 2011, Pages

  Hehrlein, Christoph ^a   Richardt, Gert ^b   Wiemer, Marcus ^c   Schneider, Henrik ^d   Naber, Christoph ^e   Hoffmann, Ellen ^f   Dietz, Ulrich ^g  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Segeberger Kliniken   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^e ELISABETH KRANKENHAUS ESSEN   (Germany)

^f KLINIKUM BOGENHAUSEN   (Germany)

^g DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

Bare metal stent; Drug eluting balloon; Drug eluting stent; In stent restenosis; Late lumen loss; Revascularisation

Indexed keywords

BUTYRYLTRI N HEXYL CITRATE; EXCIPIENT; PACLITAXEL; UNCLASSIFIED DRUG;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON CATHETER; BARE METAL STENT; CLINICAL ARTICLE; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING BALLOON; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; THERAPY EFFECT;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; FEMALE; GERMANY; HUMANS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80355149264     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7SKA20     Document Type: Article

References (21)

1. Lee MS, Pessegueiro A, Zimmer R, Jurewitz D, Tobis J. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era. J Invasive Cardiol 2008;20:401-3.
2. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21.
3. Mukherjee D. Optimal treatment for in-stent restenosis after BMS-DES, coated balloon, or scalpel? Eur Heart J 2008;29:1595-6.
4. Garg P, Mauri L. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation. Curr Opin Cardiol 2007;22:565-71.
5. Radke PW, Kaiser A, Frost C, Sigwart U. Outcome after treat- ment of coronary in-stent restenosis; results from a systematic review using meta-analysis techniques. Eur Heart J 2003;24:266-73. (Pubitemid 36207082)
6. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell ME; TAXUS V ISR Investigators. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006;295:1253-63.
7. Holmes DR Jr, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, Kuntz RE, Fitzgerald PJ, Wang H, Caramanica E, Cohen SA, SISR Investigators. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 2006;295:1264-73.
8. Ellis SG, O'Shaughnessy CD, Martin SL, Kent K, McGarry T, Turco MA, Kereiakes DJ, Popma JJ, Friedman M, Koglin J, Stone GW. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent resteno- sis: the TAXUS V ISR trial. Eur Heart J. 2008;29:1625-34.
9. http://www.cordis.com/active/crdus/en-US/html/cordis/down- loads/press/155-4156-1-JAMA.pdf. 11-8-2008. Ref Type: Internet Communication.
10. Ge H, Zhang Q, Zhou W, He Q, Han ZH, He B. Efficacy and safety of drug-eluting stent implantation for the treatment of in- stent restenosis occurring within bare-metal stent and drug-eluting stent. J Zhejiang Univ Sci B. 2010;11:553-60.
11. Axel DI, Kunert W, Göggelmann C, Oberhoff M, Herdeg C, Küttner A, Wild DH, Brehm BR, Riessen R, Köveker G, Karsch KR. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997;96:636-45. (Pubitemid 27329445)
12. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Böhm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-24. (Pubitemid 44749319)
13. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-8.
14. Hausleiter J, Jost S, Nolte CW, Dirschinger J, Kastrati A, Stiel GM, Wunderlich W, Fischer F, Linderer T, Hausmann D, Schomig A: Comparative in-vitro validation of eight first- and sec- ond-generation quantitative coronary angiography systems. Coron Artery Dis 1997;8:83-90.
15. Dietz U, Rupprecht HJ, Brennecke R, Fritsch HP, Woltmann J, Blankenberg S, Meyer J: Comparison of QCA systems. Int J Card Imaging 1997;13:271-280.
16. Herrington D, Walford G: Optimal frame selection for QCA. in Reiber JHC SP (ed): Advances in Quantitative Coronary Arteriography. The Netherlands: Kluwer Academic Publishers, 1993, 125-135.
17. Reiber JH, van Eldik Helleman P, Visser Akkerman N, Kooijman CJ, Serruys PW: Variabilities in measurement of coronary arterial dimensions resulting from variations in cineframe selection. Cathet Cardiovasc Diagn 1988;14:221-228.
18. Scheller B, EuroPCR 2010: Drug coated balloon for coronary in-stent restenosis: the clinical evidence. EuroPCR 2010 Scientific program page 120.
19. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon cathe- ter. Clin Res Cardiol 2008;97:773-81.
20. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis. Circulation 2009;119: 2986-94.
21. Mehilli J, Byrne RA, Tiroch K, Pinieck S, Schulz S, Kufner S, Massberg S, Laugwitz KL, Schomig A, Kastrati A. Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents. J Am Coll Cardiol 2010;55:2710-6.